Peptide

SS-31 Course

A mitochondria-targeted tetrapeptide investigated in clinical research.

AvailabilityClinical & regulatory review required

A consultation does not guarantee that a product can be supplied.

Background

What it is, how it developed and why it is discussed

SS-31, also known in development as elamipretide, is a mitochondria-targeted tetrapeptide studied for effects on mitochondrial membranes and bioenergetics. Clinical research has focused on defined disease settings rather than general anti-ageing use.

Evidence

Evidence, limitations and clinical context

A South African registered product and lawful indication must be confirmed before supply. Direct public purchase is disabled by default.

Clinical access

Availability requires regulatory confirmation

Online purchase remains disabled until the exact human-use product, South African registration and scheduling have been verified. A clinical assessment can still be booked to discuss appropriate options.

Clinical assessment Clinician authorisation